This work shows how to decrease the complexity of modeling exibility in proteins by reducing the number of dimensions necessary to model important macromolecular motions such as the induced-t process. Induced t occurs during the binding of a protein to other proteins, nucleic acids, or small molecules (ligands) and is a critical part of protein function. It is now widely accepted that conformational changes of proteins can affect their ability to bind other molecules and that any progress in modeling protein motion and exibility will contribute to the understanding of key biological functions. However, modeling protein exibility has proven a very dif cult task. Experimental laboratory methods, such as x-ray crystallography, produce rather limited information, while computational methods such as molecular dynamics are too slow for routine use with large systems. In this work, we show how to use the principal component analysis method, a dimensionality reduction technique, to transform the original high-dimensional representation of protein motion into a lower dimensional representation that captures the dominant modes of motions of proteins. For a medium-sized protein, this corresponds to reducing a problem with a few thousand degrees of freedom to one with less than fty. Although there is inevitably some loss in accuracy, we show that we can obtain conformations that have been observed in laboratory experiments, starting from different initial conformations and working in a drastically reduced search space.
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intense research by scientists worldwide. This amount of information is expected to grow at an even faster pace in the coming years due to new efforts in large-scale proteomics and structural genomics projects. In order to make the best use of the exponential increase in the amount of data available, it is imperative that we develop automated methods for extracting relevant information from large amounts of protein structural data. The focus of this paper is on how to obtain a reduced representation of protein exibility from raw protein structural data.
Protein exibility is a crucial aspect of the relation between protein structure and function. Proteins change their three-dimensional shapes when binding or unbinding to other molecules. Calmodulin is a representative example. This protein mediates a large number of cellular functions including ion channels, protein synthesis, gene regulation, cell motility, and secretion (Van Eldik and Watterson, 1998) . Calmodulin is constituted by two large domains connected by a tether. This protein functions by binding to other proteins, and during this process it undergoes a drastic conformational rearrangement. When the protein binds one of its targets, the tether bends over its length, and the two calcium-binding domains reorient with respect to each other as shown in Fig. 1 . Many other proteins undergo conformational rearrangements during the course of their function (Gerstein and Krebs, 1998) .
Modeling protein exibility computationally will be a major bene t to most aspects of biomolecular modeling, and we can envision several applications for our work. Currently used methods in pharmaceutical drug development use information about the 3D structure of a protein in order to nd candidate drugs. One of the steps commonly used in the drug design process is to computationally screen large databases of small chemical compounds in search for those that complement the shape of an active site of a target protein. This latter step is known as molecular docking (Martin and Willett, 1998) . Candidate drugs bind to the target protein, disrupting its function and leading to a desired pharmaceutical activity. However, during binding, some proteins undergo conformational changes in a process known as induced t, which allows for higher interaction energy between the two molecules. This experimental fact is ignored by most current docking programs due to the computational complexity of explicitly modeling all the degrees of freedom of a protein (Muegge and Rarey, 2001; Teodoro et al., 2001) . Modeling proteins as rigid structures limits the effectiveness of currently used molecular docking methods. Using the approximation described in this paper, it will be possible to include protein exibility in the drug design process in a computationally ef cient way. A second potential application of our work is to model conformational changes that occur during protein-protein and protein-DNA/RNA interactions. Most current methods for studying these interactions are also limited in accuracy and applicability because the proteins involved are modeled as rigid.
FIG. 1.
Conformations of calmodulin. The unbound form shown on the left bends the ®-helix connecting its two main domains when it binds to a target (not shown). The nal bound conformation is on the right.
Current structural biology experimental methods are restricted in the amount of information they can provide regarding protein motions because they were designed mainly to determine the three-dimensional static representation of a molecule. The two most common methods in use today are protein x-ray crystallography (Rhodes, 1993) and nuclear magnetic resonance (NMR) (Wüthrich, 1986) . The output of these techniques is a set of fx; y; zg coordinate values for each atom in a protein. Neither of these methods is able to provide us with a full description, at atomic resolution, of the structural changes that proteins undergo in a timescale relevant to their function. Such information would be ideal to understand and model proteins. The alternative to experimental methods is to use computational methods based on classical (Brooks et al., 1988) or quantum mechanics (Gogonea et al., 2001) to approximate protein exibility. However, these computations are prohibitively expensive and are not suitable for potential target applications such as the ones described in the previous paragraph. One of the reasons why the above computational methods are expensive is that they try to simulate all possible motions of the protein based on physical laws. For the case of molecular dynamics, the timestep for the numerical integration of such simulations needs to be small (in the order of femtoseconds), while relevant motions occur in a much longer timescale (microseconds to milliseconds). It is unrealistic to expect that one could routinely use molecular dynamics or quantum mechanics methods to simulate large conformational rearrangements of molecules. A medium-sized protein can have as many as several thousand atoms, and each atom can move along three degrees of freedom. Even when considering more restricted versions of protein exibility that take into account only internal torsional degrees of freedom, or restrict the degrees of freedom to take only a set of discrete values, exploring the conformational space of these proteins is still a formidable combinatorial search problem (Finn and Kavraki, 1999) .
The solution presented in this work addresses the high-dimensionality problem by transforming the basis of representation of molecular motion. Whereas in the standard representation all degrees of freedom (the fx; y; zg values for each atom) of the molecule were of equal importance, in the new representation the new degrees of freedom will be linear combinations of the original variables in such way that some degrees of freedom are signi cantly more representative of protein exibility than others. As a result, we can approximate the total molecular exibility by truncating the new basis of representation and considering only the most signi cant degrees of freedom. The remaining degrees of freedom can be disregarded, resulting in only a small inaccuracy in the molecular representation. Transformed degrees of freedom will no longer be single atom movements along the Cartesian axes but collective motions affecting the entire con guration of the protein. The main tradeoff of this method is that there is some loss of information due to truncation (of the new basis), but this factor is outweighed by the ability to effectively model protein exibility in a subspace of largely reduced dimensionality. We also show that there is inevitably some loss of accuracy, but the results are acceptable, consistent with experimental laboratory results, and help shed light on the mechanisms of biomolecular processes.
In this paper, we describe how starting from initial coordinate information from different data sources we apply the principal component analysis method of dimensionality reduction and obtain a new structural representation using collective degrees of freedom. In Section 2, we give some background on the most commonly used techniques of dimensionality reduction and some previously published applications of these in simulating and analyzing protein conformations. In Section 3, we explain how to apply the singular value decomposition method to perform the dimensionality reduction, while in Section 4 we describe the general methodology used to obtain the input data. In Section 5, we present the results we obtained from the dimensionality reduction of data for two protein systems of signi cant pharmaceutical relevance. Finally, in Section 6, we present our conclusions and discuss directions for future work.
BACKGROUND
Dimensionality-reduction techniques aim to determine the underlying true dimensionality of a discrete sampling X of an n-dimensional space. That is, if X is embedded in a subspace of dimensionality m, where m < n, then we can nd a mapping F : X ! Y such that Y ½ B and B is an m-dimensional manifold. Dimensionality reduction methods can be divided into two types: linear and nonlinear. The two most commonly used linear methods to nd such mappings are multidimensional scaling (MDS) and principal component analysis (PCA).
MDS encompasses a variety of multivariate data analysis techniques that were originally developed in mathematical psychology (Kruskal, 1964; Shepard, 1962) to search for a low-dimensional representation of high-dimensional data. The search is carried out such that the distances between the objects in the lower dimensional space match as well as possible, under some similarity measure between points in the original high-dimensional space.
PCA is a widely used technique for dimensionality reduction. This method, which was rst proposed by Pearson (1901) and further developed by Hotelling (1933) , involves a mathematical procedure that transforms the original high-dimensional set of (possibly) correlated variables into a reduced set of uncorrelated variables called principal components. These are linear combinations of the original values in which the rst principal component accounts for most of the variance in the original data, and each subsequent component accounts for as much of the remaining variance as possible. Note that if the similarity measure of MDS corresponds to the Euclidean distances then the results of MDS are equivalent to PCA. The MDS and PCA dimensionality reduction methods are fast to compute, simple to implement, and since their optimizations do not involve local minima, they are guaranteed to discover the dimensionality of a discrete sample of data on a linear subspace of the original space.
One of the limitations of methods such as MDS and PCA is that their effectiveness is limited by the fact that they are globally linear methods. As a result, if the original data is inherently nonlinear, these methods will represent the true reduced manifold in a subspace of higher dimension than necessary in order to cover nonlinearity. To overcome this limitation, several methods for nonlinear dimensionality reduction have been proposed in recent years. Among these are principal curves (Hastie and Stuetzle, 1989; Tibshirani, 1992) , multilayer auto-associative neural networks (Kramer, 1991) , local PCA (Kambhatla and Leen, 1997) , and generative topographic mapping (Bishop et al., 1998) . More recently, Tenenbaum et al. (2000) proposed the isomap method and Roweis and Saul (2000) proposed the locally linear embedding method. The main advantage of the last two methods is that the optimization procedure used to nd the low-dimensional embedding of the data does not involve local minima. In general, the main disadvantages of nonlinear versus linear dimensionality reduction methods are increased computational cost, dif culty of implementation, and problematic convergence. The development of new methods for dimensionality reduction is an active research area.
The application of dimensionality reduction methods, namely PCA, to macromolecular structural data was rst described by Garcia (1992) in order to identify high-amplitude modes of uctuations in macromolecular dynamics simulations. It as also been used to identify and study protein conformational substates (Caves et al., 1998; Kitao and Go, 1999; Romo et al., 1995) as a possible method to extend the timescale of molecular dynamics simulations (Amadei et al., 1993; Amadei et al., 1996) and as a method to perform conformational sampling (de Groot et al., 1996a (de Groot et al., , 1996b . The validity of the method has also been established by comparison with laboratory experimentally derived data (de Groot et al., 1998; van Aalten et al., 1997 ). An alternative approach to determine collective modes for proteins uses normal mode analysis (Go et al., 1983; Levitt et al., 1985; Levy and Karplus, 1979) and can also serve as a basis for modeling the exibility of large molecules (Zacharias and Sklenar, 1999) . Normal modes analysis is a direct way to analyze vibrational motions. To determine the vibrational motions of a molecular system, the eigenvalues and the eigenvectors of a mass-weighted matrix of the second derivatives of the potential function are computed. The eigenvectors correspond to collective motions of the molecule, and the eigenvalues are proportional to the squares of the vibrational frequencies. The PCA approach described in this article avoids some of the limitations of normal modes, such as lack of solvent modeling, assumption that the potential energy varies quadratically, and existence of multiple energy minima during large conformational transitions. In contrast to previously published work, we focus on the interpretation of the principal components as biologically relevant motions and on how combinations of a reduced number of these motions can approximate alternative conformations of the protein.
PCA OF CONFORMATIONAL DATA

Method
In this paper, we focus our analysis on the application of PCA to protein structural data. For our study, we chose PCA as the dimensionality reduction technique because it is very well established and ef cient algorithms with guaranteed convergence for its computation are readily available. PCA has the advantage over other available methods that the principal components have a direct physical interpretation. As explained later, PCA expresses a new basis for protein motion in terms of the left singular vectors of the matrix of conformational data. The left singular vectors with largest singular values correspond to the principal components. When the principal components are mapped back to the protein structure under investigation, they relate to actual protein movements, also known as modes of motion. It is now possible to de ne a lower dimensional subspace of protein motion spanned by the principal components and use these to project the initial high-dimensional data onto this subspace. The inverse operation can also be carried out, and it is possible to recover the high-dimensional space with minimal reconstruction error. By contrast, recovering the high-dimensional representation is not readily achievable when using MDS because the de nition of the low-dimensional subspace is implicit in the projection and is not de ned directly by the left singular vectors as is the case for PCA. The quality of the dimensionality reduction obtained using PCA can be seen as an upper bound on how much we can reduce the representation of conformational exibility in proteins. The reason for this is that PCA is a linear dimensionality reduction technique and protein motion is in general nonlinear (Garcia, 1992) . Hence, it should be possible to obtain an even lower dimensional representation using nonlinear methods. However, we wanted to test the overall approach before proceeding to more expensive methods. For nonlinear methods, the inverse mapping needs to be obtained using, for example, a neural network approach, but the feasibility and ef ciency of these mappings has not been tested so far. There is active research in this area and our work will bene t from any progress.
In PCA, principal components are determined so that the rst principal component PC .1/ is a linear combination of the initial variables A j , with j D 1; 2; : : : ; n. That is,
where the weights w .1/1 ; w .1/2 ; : : : ; w .1/n have been chosen to maximize the ratio of variance of PC .1/ to the total variation, under the constraint
Other principal components PC .p/ are similarly linear combinations of the observed variables which are uncorrelated with PC .1/ ; : : : ; PC .p¡1/ and account for most of the remaining total variation. Although it is possible to determine as many principal components as the number of original variables, this method is typically used to determine the smallest number of uncorrelated principal components that explain a large percentage of the total variation in the data. The exact number of principal components chosen is application dependent and constitutes a truncated basis of representation.
Conformational data
The data used as input for PCA is in the form of several atomic displacement vectors corresponding to different structural conformations which together constitute a vector set. We will call this set the conformational vector set. Each vector in the conformational vector set has dimension 3N , where N is the number of atoms in the protein being studied and is of the form [x 1 ; y 1 ; z 1 ; x 2 ; y 2 ; z 2 ; : : : ; x N ; y N ; z N ], where [x i ; y i ; z i ] corresponds to Cartesian coordinate information for the i th atom. The rst step in the generation of the atomic displacement vectors is to determine the average protein vector for each conformational vector set. This is achieved by rst removing the translational and rotational degrees of freedom from the considered molecule by doing a rigid least squares t (Kabsch, 1976) of all the structures to one of the structures in the vector set and then averaging the values for each of the 3N degrees of freedom. The resulting average structure vector is then subtracted from all other structures in the conformational vector set to compute the nal atomic displacement vectors.
Singular valve decomposition (SVD)
In this work, we use the singular value decomposition (SVD) as an ef cient computational method to calculate the principal components (Romo, 1998) . The SVD of a matrix, A, is de ned as
where U and V are orthonormal matrices and 6 is a nonnegative diagonal matrix whose diagonal elements are the singular values of A. The columns of matrices U and V are called the left and right singular vectors, respectively. The square of each singular value corresponds to the variance of the data in A along its corresponding left singular vector, and the trace of 6 is the total variance in A. For our purposes, matrix A is constructed by the column-wise concatenation of the elements of a conformational vector set. If there are m conformations of size 3N in the vector set, this results in a matrix of size 3N £ m. The left singular vectors of the SVD of A are equivalent to the principal components (Romo, 1998) and will span the space sampled by the original data. The right singular vectors are projections of the original data along the principal components. The right singular vectors also provide useful molecular information by helping to identify preferred protein conformations (Romo et al., 1995; Teodoro et al., 2000) . For this paper, we construct A using the conformational vector sets of Section 4. The SVD of matrix A was computed using the ARPACK library (Lehoucq et al., 1998) . ARPACK is a collection of Fortran77 subroutines designed to solve large-scale eigenvalue problems. It is based upon an algorithmic variant of the Arnoldi process called the Implicitly Restarted Arnoldi Method (Lehoucq and Sorensen, 1996) .
OBTAINING CONFORMATIONAL DATA
Ideally, the input data for dimensionality reduction would come from an accurate experimental technique that would permit the determination of the 3D structure at atomic resolution as it changes as a function of time. Using such a technique, we could collect a large number of samples at short time intervals (picosecond to nanosecond intervals). Unfortunately, such an experimental technique is not currently available. In order to perform the dimensionality reduction, we need to obtain as much data as possible about the protein system being studied from all available sources. The most common data sources are the experimental laboratory methods of x-ray crystallography and NMR, and force eld based computational sampling methods such as molecular dynamics. Of these, the laboratory methods generate less data but do it with a greater accuracy.
X-ray crystallography
The most established and accurate method of determining the structure of a protein is protein x-ray crystallography (Rhodes, 1993) . This technique is based on the collection of diffraction data generated by exposing a protein crystal to an x-ray beam. The experimental diffraction data is then computationally processed to yield a three-dimensional representation of the electron cloud of the molecule under study. Using these electron maps, it is then possible to accurately determine the spatial position of protein atoms in a process called tting. The nal outcome of the structural determination process is a single set of coordinates of all atoms in the molecule. The main limitation of this experimental technique is that it is necessary to obtain protein crystals in order to collect experimental data. Unfortunately, generating protein crystals is a very lengthy and laborious process which is not always successful. For example, membrane proteins, which are extremely important biologically, are notoriously dif cult to crystallize, and very few structures of this class of proteins have been determined to date (Byrne and Iwata, 2002) .
X-ray crystallography is sensitive to the experimental conditions under which it is performed, and changes of these conditions change the result. However, this a priori disadvantage can be sometimes bene cial. For example, by determining the structure of a protein in the presence of different inhibitors, we can determine different binding modes for potential drug candidates and observe how the protein is able to adapt to different molecules. For a number of interesting molecules, there are several structures available, and our analysis can be performed directly on the conformational vector set de ned collectively by the experimental structures. This constitutes an advantage since no errors are introduced by the approximations used in current computational methods. One example of such a protein is HIV-1 protease. For this system, there are several publicly available structures of the protein bound to widely different inhibitors. This is possible because the binding site of this protease is very exible and is able to change its shape in order to complement the three-dimensional shape of the smaller molecules that bind to it (ligands). By analyzing the conformational data using a dimensionality reduction method such as PCA, we are able to reduce the overwhelming amount of information obtained from dozens of different structures to a small set of motions that summarize how the protein is able to adjust the shape of its binding site.
Nuclear magnetic resonance (NMR)
The second most common method of determining the structure of a protein is NMR (Wüthrich, 1986) . This method uses a spectroscopy approach to collect the experimental data necessary for structure determination. The most important data obtained is a set of NOE (nuclear Overhauser effect) intensities produced by dipolar relaxation from neighboring spin systems. This intensity is inversely proportional to the distance between the spin systems, and as such it is possible to collect a series of distance constraints between atoms which enable the determination of the three-dimensional structure of a protein by solving a distance geometry problem (Guntert et al., 1991) .
This method is in general not as accurate as x-ray crystallography, and its use is limited to small and medium-sized proteins. However, it provides useful information about protein dynamics directly and avoids some of the problems of x-ray crystallography, such as protein crystallization. Another advantage of using NMR structures is that the nal solution is not a single structure but a family of structures as required for input for dimensionality reduction. Although this family is usually composed of 10 to 50 structures, this number can be made as large as necessary by deriving more structures that satisfy the NMR experimental constraints to the same level as the original number. It is not clear, however, if new information is always useful for the dimensionality reduction technique since all the structures in the family are derived from the same set of experimental observations. Structures derived using either x-ray crystallography or NMR are stored in major databanks, such as the Protein Data Bank (Berman et al., 2000) .
Molecular dynamics (MD)
An alternative to using experimental methods to derive structural data is using computational methods such as MD (Brooks et al., 1988) . In fact, computational methods are used to augment existing experimental data since MD simulations typically start from a three-dimensional protein structure determined by x-ray crystallography or NMR. MD uses a force eld (Cornell et al., 1995; MacKerell et al., 1998) to approximate the potential energy surface of a protein. The force eld measures energy through a combination of bonded terms (bond distances, bond angles, torsional angles, etc.) and nonbonded terms (van der Waals and electrostatics). The relative contributions of these terms are different for the different types of atoms in the simulated molecule. They are determined by adjusting a series of parameters so that the molecule displays characteristics that have been observed experimentally or have been calculated from rst principles. Once the force eld has been speci ed, the time evolution of the system at an atomic scale is determined by solving Newton's equations of motion. One of the main disadvantages of MD is that it is very computationally expensive, which makes it impossible to run simulations for a timescale relevant to a majority of biological processes. Given current computer hardware, the timescales that are practically feasible to simulate even for a medium sized protein are usually less than 10-50 ns. The longest simulation published so far is 1 ¹s (Duan and Kollman, 1998) . These simulations can take from days to months of computer time, even on parallel machines, depending on the timescale simulated and the complexity of the molecular model. Nonetheless, shorter simulations can provide us with invaluable data since they are the only method of observing proteins in "real time" and with atomic detail. For the purposes of determining a set of collective modes of motion representing the exibility of the protein, it has been veri ed that it is only necessary to run short MD simulations (< 1 ns) (de Groot et al., 1996c) because the subspace spanned by the calculated left singular vectors derived from MD converge quickly.
MD is a good data source for our purposes because it can provide a large number of conformations of a molecule. However, MD is not as accurate as experimental methods due to approximations introduced in the computational process in order to make the MD simulation computationally practical. Among these approximations is the over simpli ed treatment of solvation effects and the lack of polarizability representation in commonly used force elds. Addressing some of these limitations is currently the focus of many researchers, and there have been signi cant advances in the area of continuum electrostatic models and polarizable force elds. Improvements to the data generated by computational methods will re ect positively on the quality of the information that is obtained using dimensionality reduction.
When carrying out the dimensionality reduction described in this work, we must chose among the data sources which are available for the molecular system being studied. It is unlikely that data from all sources described in this section will be available simultaneously for any particular system. Furthermore, data obtained using exclusively experimental data sources is especially dif cult to obtain. However, the availability of experimental data is very likely to increase in the future due to methodological improvements resulting from increased automation advances resulting in part from structural genomics projects. In the next section, we apply our method to two model systems using available sources of data.
APPLICATION TO SPECIFIC SYSTEMS
HIV-1 protease
The rst model system used in this study is HIV-1 protease. HIV-1 protease is a homodimeric aspartyl protease with each subunit containing 99 residues. The active site of HIV-1 protease is formed by the homodimer interface and is capped by two identical¯-hairpin loops from each monomer, which are referred usually as aps (see Fig. 2 ). This protein plays a critical role in the maturation of the HIV-1 virus and has been the focus of intensive research in both academic and pharmaceutical communities. As a result, there is a large quantity of structural information on this system. This protein is known (Collins et al., 1995) to undergo a large conformational rearrangement during the binding process consisting of the opening and closing of the aps over its binding site. The conformations of the open and closed forms are overlapped in Fig. 2 .
There are approximately 150 experimental structures available in public databases (http://srdata.nist. gov/hivdb/ and http://www.rcsb.org/pdb/) for this system, and this number is continually growing due to its pharmaceutical importance. Of these structures, many are bound to different ligands and, depending on the size and shape of the ligand, display widely different conformations of the residues in the binding site. It has been observed that the volume of the cavity can approximately double depending on the ligand. In Fig. 3 , we show a tube representation of HIV-1 protease bound to two different inhibitors. The structures shown correspond to PDB access code 4HVP and 1AID. As can be seen in the gure, the protease is able to change its shape mostly in the aps region to accommodate for different ligands which vary considerably in terms of shape and volume. HIV-1 protease provides an excellent demonstration of protein plasticity and underlines the importance of understanding and modeling protein exibility for binding purposes.
One of the advantages of using the PCA methodology to analyze protein exibility is that it can be used at different levels of detail depending on what kind of information we are interested in obtaining. For example, if we are interested in the overall motion of the backbone, then we can construct the matrix A de ned in Section 3 using only the coordinate information from the ®-carbons. This reduces the number of degrees of freedom to 3 £ 198 and makes the computation of the SVD faster. Alternatively, we can include all the atoms of the protein for a total of 3 £ 3,120 degrees of freedom and be able to observe the simpli ed exibility of the protein as a whole. As an intermediate case, we can include only the atoms that constitute the binding site to study how it can change shape during the binding of different ligands. This intermediate solution would probably be better for a drug design study. Below, we describe the results obtained for all three cases above.
In the rst experiment, we determined the modes of motion generated from MD data. The initial structure used for the simulation was determined by x-ray crystallography (Miller et al., 1989 ) (PDB access code 4HVP). Molecular dynamics simulations for this system were carried out with the program NAMD2 (Kalé et al., 1999) using the charmm22 force eld (MacKerell et al., 1998) . Since we were mostly interested in conformational changes in the binding site of this protein, we did not include any inhibitor in the simulation in order to be able to observe a larger range of conformational motions in this region. The simulations were carried out in a box of TIP3 water using periodic boundary conditions, particle mesh Ewald full electrostatic integration, and pressure and temperature coupling using the Berendsen algorithm (Berendsen et al., 1984) . After an equilibration period of 200 picoseconds, the simulations were carried out for an extra 1.4 nanoseconds each at a temperature of 300K, and structures were saved to disk every 100 femtoseconds. The resulting 14,000 structures were used in the dimensionality reduction procedure.
In Fig. 4 , we show the fraction of the total variance explained by the 20 most signi cant left singular vectors for the SVD analysis of the coordinate data for all 198 ®-carbons in HIV-1 protease. The largest singular value accounts for 35% of the total variance. The rst 3 and rst 20 account for 53% and 80%, respectively. In practice, this means that we can approximate a system of 596 dimensions using only 20 dimensions and are still able to retain 80% of the variance in the original data. This results in a drastic reduction of complexity with only a small reduction in our ability to represent different conformations of HIV-1 protease. In Fig. 5 , we show the motion of the backbone that was captured in the rst principal component. This motion matches well with the opening and closing of the binding site, a fact that has been determined experimentally (Fig. 2) . It also shows the strength of this method in isolating the most relevant biological motions from a large amount of high-dimensional input data where they were not clearly recognizable. The reason why it is dif cult, even for an expert, to recognize these principal motions directly from the raw MD data is the enormous quantity of information generated by this technique. PCA also reveals the tendency of the protein to move in a certain direction even though this movement is not fully explored during the MD run. This constitutes one of the main advantages of this method since it enables the discovery of the important motions using shorter MD simulations with a consequent drastic reduction in computational cost.
It is important to emphasize at this point that no bias was introduced at any point in the calculation that would inevitably lead to the observed result. The input to the data reduction consisted uniquely of MD sampling data obtained from a short simulation starting from the bound conformation without the ligand. What is being captured is the opening caused by the removal of the ligand without driving the simulation directly to the nal open conformation as is the case for the steered MD technique (SMD) (Isralewitz et al., 2001) . The reason we avoid this alternative is that we want to validate the utility of using MD simulations when only one experimental structure is known for the system of study. We do not want to introduce any bias to the system as SMD would do.
The results obtained from SVD for all atoms were similar to the ®-carbon approximation but contain extra information about amino acid sidechain movements. The most dominant, the rst three, and the rst twenty left singular vectors account for 20%, 37%, and 68% of the total variance, respectively. These values are smaller than for the ®-carbon carbon dimensionality reduction because the total number of degrees of freedom considered is much larger. It is again clear from these values that in the new basis only a few degrees of freedom account for most of the conformational variation.
One advantage of using the HIV-1 protease as a model system is the wealth of structural information publicly available for this protein. It is possible to carry out the same type of dimensionality reduction work using only laboratory-determined structures of HIV-1 protease bound to different ligands. Here, we present results of applying PCA to x-ray crystallographic data. A similar analysis is possible using families of structures derived from NMR data. We used 130 structures of HIV-1 protease deposited in the Protein Data Bank. The coordinates of the different ligands bound to the structures were not included in the calculations. The fraction of total variance represented by the most signi cant singular values for the PCA of the ®-carbon coordinate information using exclusively laboratory derived data is also shown in Fig. 4 . This result is similar to the result obtained from the MD data. The most signi cant left singular vector accounts for 30% of the total variance, and the rst 20 account for 85%.
As a nal validation of our method, we decided to investigate if, using the main modes of motion de ned by the principal components and an experimental structure bound to a particular ligand, we could approximate the structure of HIV-1 protease bound to a different ligand. For this experiment, we were only concerned with variations in the shape of the binding site and computed the dimensionality reduction only for this part of the protein. We de ned the binding site atoms as those that are part of amino acids that touch the ligand directly in any of the x-ray structures in the PDB. A total of 266 atoms were identi ed. As the initial reference, we chose the same structure we used for the MD simulation, and as a target structure, we used a complex with a large nonpeptide inhibitor (Rutenber et al., 1993) (PBD access code 1AID). The binding site conformations as well as the inhibitors bound to these are considerably different as shown in Fig. 3 . The root mean square deviation (RMSD) between the two proteins is 1.86 Å if we take into account only the atoms that constitute the binding site.
The next step was to calculate the coordinates of the target structure in the new basis. For this, we used the de nition of the representation basis given by the principal components of the MD data, and we set the origin of the space to be our reference structure. The coordinates in each of the dimensions are given by the dot product of the atomic displacement vector and the left singular vector de ning each dimension. The resulting coordinates will be a solution vector of the form [w 1 ; w 2 ; w 3 ; w 4 ; : : : ; w 3N ]. We can now calculate what would be the RMSD between our target structure and our low-dimensional approximation. The approximation corresponds to [w 1 ; 0; 0; 0; : : : ; 0] if we consider only the rst collective mode, [w 1 ; w 2 ; 0; 0; : : : ; 0] if we consider the rst two, and [w 1 ; w 2 ; w 3 ; w 4 ; : : : ; w k ; 0; : : : ; 0] if we consider the rst k collective modes. The RMSD results for an increasing number of collective modes are shown in Fig. 6 . When using the PCA basis, we are able to approximate the target structure to an RMSD of less than 1 Å using 40 principal components out of a total of 798. By contrast, if we used an approximation with a random orthonormal basis (Wolfram, 1999) de ning the same space (shown by a broken line in Fig. 6 ), we would need more that 650 principal components to obtain the same accuracy. This shows the strength of our method in approximating other conformations of the same protein using a lower dimensional search space and validates the effectiveness of the PCA by comparing it with an approximation carried out using a random basis. It is also important to note that the values that we obtain for the approximation to the target can be further improved. Currently, we are using the projection of the target structure on the new basis to estimate a set of coordinates in the reduced space that approximate the target structure. However, the optimal approach is to search the low-dimensional space directly to look for the best match. In this way, we can search for alternative coordinate values along the most signi cant principal components that compensate for the approximation being introduced by the dimensional truncation of the representation basis. We are currently developing search techniques for the purpose of nding these solutions in the reduced space.
Aldose reductase
The second model system used in our study is aldose reductase. The biological function of this enzyme is yet not entirely known but it is believed to play a primary role in the development of severe degenerative complications of diabetes mellitus (Larson et al., 1988) . Finding new inhibitors for this protein could potentially lessen some of the complications of diabetes. Unfortunately, just like in the case of the previous example and like many other proteins, aldose reductase has the capacity to adjust the shape of its binding site depending on the ligand it is binding to. A small-molecule database screen for potential ligands would miss many potential candidates if it did not include the protein exibility in the search process. Several experimental structures of aldose reductase have been solved using x-ray crystallography when bound to different ligands as well as in the unbound form. It was observed that with some inhibitors such as sorbinil (Urzhumtsev et al., 1997) , the structure is almost similar to the unbound form. For other inhibitors, such as the tolrestat (Urzhumtsev et al., 1997) and zopolrestat (Wilson et al., 1993) , there is a formation of a speci city pocket resulting in signi cantly different binding site con gurations. This conformational change is shown in Fig. 7 where we compare the shape of the binding site for the unbound form of the enzyme to the bound form with tolrestat. In the unbound form shown on the left of Fig. 7 , there are a series of amino acids (represented by ball-and-stick models), which come together to close the speci city pocket. In the presence of tolrestat (represented on the right by a van der Waals sphere model), the amino Although there are currently 16 structures of aldose reductase deposited in the PDB, we cannot use this data exclusively as input for the dimensionality reduction technique as we did for HIV-1 protease. The reason is that the data does not contain much variability, as only two ligands are signi cantly different from the rest. In this case, we have to complement laboratory obtained structures with data obtained from an MD simulation. This will be typically the case with most protein systems of interest for drug design, as few structures have been determined under different sets of experimental conditions and with different ligands. The starting structure for the MD simulation was the unbound form with PDB code 1AH4. The MD and PCA procedures used for this example were similar to what was described above for HIV-1 protease. However, since the system is larger (315 versus 198 aminoacids for HIV-1 protease) and it is known from crystallography observations that only the binding site region changes its shape, we decided to apply our dimensionality reduction technique only to this region. We conservatively de ned the binding site to be a sphere of radius 20 Å around the center of the tolrestat speci city pocket (see Fig. 7 ). This changed the dimensionality of the input data from 3 £ 5,121 to 3 £ 2,544.
Again, as it was observed with HIV-1 protease, there is a large dominance of only a small fraction of the left singular vectors. The 40 most dominant vectors account for 81% of the total variance (Fig. 8) , with the rst three accounting for 22%, 11%, and 6% of the total variance, respectively. If we consider the new reduced basis of 40 dominant left singular vectors (versus the initial 3 £ 2,544) as a representation for the exibility of the binding site, we can now model on our reduced basis some of the exibility that is experimentally observed. For this, we calculated an approximation of the form [w 1 ; w 2 ; : : : ; w 40 ; 0; : : : ; 0] as we did for HIV-1 protease using the unbound form as the reference structure (no pocket present) and the bound structure to tolrestat as our target (pocket is present). The RMSD for the binding site residues represented in Fig. 9 between the bound (shown in light gray) and unbound form (shown in black) is 1.74 Å. Using a 40 degrees of freedom approximation, we can reduce this value to 1.07 Å. From the gure, it is clear that we can obtain a good approximation on the residues that form the top of the speci city pocket with our approximate structure (shown in gray) matching almost exactly the experimental structure for the bound form. It is important to note that the approximation is able to capture not only the movement of amino acid sidechains, such as the rotation of the phenylalanine ring shown in the center, but also global displacements caused by a movement at the backbone level, such as shown in the top of Fig. 9 . This contrasts with complexity reduction methods that consider the important exibility of the protein as being represented only by movements of sidechains and which are unable to represent induced t conformational changes caused by backbone movements. The bottom part of the speci city pocket does not show a match of similar quality but does show a trend in the right direction. In fact, the approximated structure already displays the speci city pocket and is large enough to accommodate ligands such as tolrestat or zopolrestat.
CONCLUSION
In this paper, we showed how to obtain a reduced basis representation of protein exibility. Proteins typically have a few hundreds to a few thousands of degrees of freedom. Starting with data obtained from laboratory experiments and/or MD simulations, we demonstrate that we can compute a new set of degrees of freedom which are combinations of the original ones and which can be ranked according to signi cance. Depending on the level of accuracy desired, the k most signi cant of these new degrees of freedom can be used to model the exibility of the system. We have observed, in multiple occasions, that the reduced basis representation retains critical information about the directions of preferred motion of the protein. It can thus be used to compute conformational rearrangements of the protein that can further be studied for interaction with novel ligands or other proteins. Our work contributes to the better understanding of how changes in the conformation of a protein affect its ability to bind other molecules and hence of its function. We envision that protein databases, such as the Protein Data Bank, would be annotated in the future with principal modes of motion for proteins allowing rapid and detailed analysis of biomolecular interactions. This annotation would allow researchers to analyze not only the static structure of a protein but also its motions and relations between structure, motion, and function. The process of determining collective modes of motion could be automated using the methods described in the present work, and the information would complement other structural databases, such as the Database of Macromolecular Movements (Gerstein and Krebs, 1998) .
In this paper, we used PCA as our dimensionality reduction technique. The results obtained are biologically meaningful. Clearly, it is worth investigating the application of nonlinear dimensionality reduction techniques to the same problem. For example, local PCA (Kambhatla and Leen, 1997) , locally linear embedding (Roweis and Saul, 2000) , and multilayer auto-associative neural networks (Kramer, 1991) might be able to provide us with the same kind of information as PCA while using an even further reduced number of degrees of freedom. The application of these dimensionality reduction methods to protein structural data is only practical for modeling if we are able to obtain an inverse mapping from the lower to the higher dimensional space. This mapping can in principle be obtained using machine learning techniques such as neural networks. Carrying out this step ef ciently is very dif cult and constitutes an open research question.
Preliminary work in our group indicates that some of the advantages obtained by performing a nonlinear dimensional reduction are outweighed by an increased computational cost and a loss in accuracy due to the approximated inverse mapping. Nevertheless, the advantage of reduced complexity in the representation of molecular motion may justify the increased computational cost of the nonlinear dimensionality reduction depending on the application.
All our work was done using the Cartesian coordinates of atoms in the protein. An interesting idea is to perform the dimension reduction in the dihedral and the bond angle space of the system. The advantage of this approach is that the initial dimensionality of the problem is reduced because given certain constraints fewer parameters are necessary to uniquely de ne a protein structure. The rst constraint is that bond lengths are xed. At a second level of approximation, bond angles between three consecutively bonded atoms can also be considered xed. As such, it is possible to represent a molecular conformation using only the set of dihedral angles corresponding to torsions around single bonds. The dimensionality of this space is in practice approximately almost an order of magnitude smaller than the Cartesian representation. Initial experiments showed that a dihedral angle-based analysis of conformational data is very sensitive to noise and prone to error. We are currently investigating this problem and improving the general methodology in order to apply the methods described in this work to a dihedral angle representation. Last but not least, we investigate how to effectively explore conformational exibility of a protein in the reduced basis representation to make approximate but fairly accurate predictions for protein-protein and protein-ligand interactions. This work could be used to predict complex effects, such as the induced t effect during ligand binding in a drug design study, in a computationally ef cient manner.
